![DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program](https://sophieprogram.ca/wp-content/uploads/sites/11/2023/11/DiagnaMed-768x443.jpg)
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
Medtech company DiagnaMed leverages the SOPHIE program to accelerate commercialization timelines of CERVAI™, their novel brain health AI platform.